The clinical trials development in Romania is still affected by the COVID-19 outbreak and by the backlog that has to be solved with new solutions to accelerate the studies approval. During the online roundtable organized by AVANTYO on the 7th of August, 2020, at 13:00, the competent authorities will disclose new information on this matter.
With the series of regular meetings with the regulatory authorities, AVANTYO Institute of Clinical Research aims to facilitate new clarifications regarding a better development of the clinical trials in Romania.
This event is the second online roundtable organized by our company. With this series of events, we bring together around the same roundtable representatives of the authorities and pharmaceutical companies and contract research organizations to find new ways of improvement and move forward.
Dr Cristina Florescu Moraid - CEO of AVANTYO Institute of Clinical Research will host the event.
On behalf of the National Agency for Drugs and Medical Devices Romania (NADMDR /ANMDMR) will attend as special guests Dr Bujor Eugen Almasan - President, Dr Mirela Vita - Lead of Clinical Trials Department and Dr Adina Pirvu - GCP Inspector.
Prof Dr Constantin Mircioiu will represent the National Commission for Bioethics of Medicines and Medical Devices (NCBMMD/CNCMDM)
The online registration is open until Thursday, 6th of August, 2020, at noon.
The event will be held on ZOOM, in Romanian, during an hour and it is free of charge.
Click here to register. https://www.avantyo.com/roundtables/regular-meeting-with-authorities-aug2020
.
